Fluorogenic Cephalosporin Substrates for β-lactamase TEM-1
Overview
Affiliations
Cephalosporin was used to synthesize soluble and precipitating fluorogenic β-lactam substrates that demonstrated differential catalytic hydrolysis by three different subtypes of β-lactamase: TEM-1 (class A), p99 (class C), and a Bacillus cereus enzyme sold by Genzyme (class B). The most successful soluble substrate contained difluorofluorescein (Oregon Green 488) ligated to two cephalosporin moieties that, therefore, required two turnovers to produce the fluorescent Oregon Green 488 leaving group. The bis-cephalosporin modification was required so that the final reaction product was the Oregon Green 488 carboxylic acid rather than a less bright phenolic adduct of the dye. Hydrolysis in pH 5.5 Mes and pH 7.2 phosphate-buffered saline (PBS) buffers was similar, but in pH 8.0 Tris the hydrolysis rate nearly doubled. Activity of the β-lactamases on the various substrates was shown to depend highly on the linker between the cephalosporin and the fluorophore, with an allyl linker promoting faster turnover than a phenol ether linker. Measured K(m) values for dichlorofluorescein and difluorofluorescein cephalosporin substrates were approximately the same as K(m) values for penicillin G and ampicillin found in the literature (~30-40μM).
Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors.
Rotter M, Zentgraf S, Weizel L, Frank D, Burgers L, Brunst S Molecules. 2023; 28(4).
PMID: 36838971 PMC: 9962638. DOI: 10.3390/molecules28041984.
Nervig C, Hatch S, Owen S ACS Med Chem Lett. 2022; 13(11):1769-1775.
PMID: 36385932 PMC: 9661694. DOI: 10.1021/acsmedchemlett.2c00394.
Yahiaoui S, Voos K, Haupenthal J, Wichelhaus T, Frank D, Weizel L RSC Med Chem. 2021; 12(10):1698-1708.
PMID: 34778771 PMC: 8528214. DOI: 10.1039/d1md00187f.
Krasavin M, Zhukovsky D, Solovyev I, Barkhatova D, Darin D, Frank D ChemMedChem. 2021; 16(22):3410-3417.
PMID: 34184833 PMC: 9290507. DOI: 10.1002/cmdc.202100344.
Fluorescent antibiotics for real-time tracking of pathogenic bacteria.
Miao L, Liu W, Qiao Q, Li X, Xu Z J Pharm Anal. 2020; 10(5):444-451.
PMID: 33133728 PMC: 7591806. DOI: 10.1016/j.jpha.2020.09.003.